SCHEMBL19080296

SCHEMBL19080296

c1ccc2cc(-c3c4ccccc4c(-c4ccc(-c5ccc6c(c5)c5ccccc5c5c7ccc8ccccc8c7sc65)cc4)c4ccccc34)ccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 6/20 0.37
CYP1B1 Q16678 6/20 0.37
CYP1A2 P05177 4/20 0.37
ESR1 P03372 2/20 0.36
ESR2 Q92731 2/20 0.36
MAPK9 P45984 1/20 0.33
MAPK14 Q16539 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
HPRT1 P00492 3/20 0.33
ALOX5 P09917 2/20 0.33
HSD17B1 P14061 1/20 0.32
HSD17B2 P37059 1/20 0.32
PDE9A O76083 1/20 0.31
ALDH1A1 P00352 1/20 0.31
THRB P10828 1/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
CYP17A1 P05093 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080325 0.95 CYP1A1 (0.43) CYP1A1CYP1B1CYP1A2ESR1ESR2
SCHEMBL19080308 0.95 ESR1 (0.38) CYP1A1CYP1B1CYP1A2ESR1ESR2
SCHEMBL19080299 0.93 ESR1 (0.39) CYP1A1CYP1B1CYP1A2ESR1ESR2
SCHEMBL19080231 0.92 CYP1A1 (0.45) CYP1A1CYP1B1CYP1A2ESR1ESR2
SCHEMBL22155619 0.92 CYP1A2 (0.36) CYP1A1CYP1B1CYP1A2ESR1ESR2
SCHEMBL19080291 0.89 CYP1B1 (0.42) CYP1A1CYP1B1CYP1A2ESR1ESR2
SCHEMBL22155432 0.89 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2MAPK9MAPK14
SCHEMBL19080361 0.89 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2MAPK9MAPK14
SCHEMBL17944858 0.89 PTPN1 (0.36) CYP1A1CYP1B1CYP1A2ESR1ESR2
SCHEMBL19080331 0.88 ESR1 (0.40) CYP1A1CYP1B1CYP1A2ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885CYP1A2 621/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885CYP1A2 621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.